Floatz logo

Quadrivalent Inactivated Influenza Vaccine

Obesity

Women's and Children's Hospital, AustraliavaccineDormant
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
59/ 100

Competitive context

575 Active assets in the Obesity cohort.

Asset / SponsorPhaseRating
vi-0521
VIVUS LLC
Phase 4BBB
Efsubaglutide Alfa
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4BBB
Tirzepatide
LABORATORIOS INDUFAR
Phase 4BBB
asc30
Ascletis Pharma (China) Co., Limited
Phase 2BBB
Deoxycholic Acid
University of California, San Diego
Phase 4BBB

View all 50 →

Same molecule, other indications

Quadrivalent Inactivated Influenza Vaccine is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
69 / 100
View asset →
viral infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →
lung cancerDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →